XML 29 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
INVESTMENT IN UNCONSOLIDATED ENTITIES (Tables)
12 Months Ended
Dec. 31, 2012
Neuro Partners LLC and CGK [Member]
 
Schedule of Equity Method Investments [Line Items]  
Summarized Financial Information
Neuro Partners LLC  and CGK Condensed Income Statement Information
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Year Ended
 
 
December 31,
 
 
2012
 
 
2011
 
 
2010
 
 
 
 
 
 
 
 
 
 
Patient Revenue
$
1,023,000
$
1,197,000
$
765,000
Rental Income
888,000
888,000
828,000
Net sales
 
$
1,911,000
 
 
$
2,085,000
 
 
$
1,593,000
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
 
$
(108,000
)
 
$
(95,000
)
 
$
(467,000
)
 
 
 
 
 
 
 
 
 
 
 
 
USNC's equity in income (loss) of Neuro Partners LLC and CGK
 
$
(34,000
)
 
$
(23,000
)
 
$
(135,000
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Neuro Partners LLC and CGK Condensed Balance Sheet Information
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
December 31,
 
 
 
2012
 
 
 
2011
 
 
 
 
 
 
 
 
 
Current assets
 
$
468,000
 
 
$
607,000
 
 
 
 
 
 
 
 
 
Noncurrent assets
 
$
2,261,000
 
 
$
2,603,000
 
 
 
 
 
 
 
 
 
Total assets
 
$
2,729,000
 
 
$
3,210,000
 
 
 
 
 
 
 
 
 
Current liabilities
 
$
442,000
 
 
$
440,000
 
 
 
 
 
 
 
 
 
Noncurrent liabilities
 
$
2,896,000
 
 
$
3,169,000
 
 
 
 
 
 
 
 
 
Equity
 
$
(609,000
)
 
$
(399,000)
 
 
 
 
 
 
 
 
 
Total liabilities and equity
 
$
2,729,000
 
 
$
3,210,000
 
 
FOP and FOPRE [Member]
 
Schedule of Equity Method Investments [Line Items]  
Summarized Financial Information
FOP and FOPRE Condensed Income Statement Information
 
 
 
 
 
Year Ended December 31,
 
 
2012
 
 
2011
 
 
2010
 
 
 
 
 
 
 
 
 
 
Patient revenue
 
$
3,251,000
 
 
$
2,117,000
 
 
$
-
 
Rental income
90,000
-
     Net sales
3,341,000
2,117,000
-
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
 
$
503,000
 
 
$
469,000
 
 
$
(118,000
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 USNC's equity in income (loss) of of FOP and FOPRE
 
$
106,000
 
 
$
94,000
 
 
$
(24,000
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FOP and FOPRE Condensed Balance Sheet Information
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
December 31,
 
 
 
2012
 
 
 
2011
 
 
 
 
 
 
 
 
 
Current assets
 
$
919,000
 
 
$
1,524,000
 
 
 
 
 
 
 
 
 
Noncurrent assets
 
$
6,374,000
 
 
$
5,717,000
 
 
 
 
 
 
 
 
 
Total assets
 
$
7,293,000
 
 
$
7,241,000
 
 
 
 
 
 
 
 
 
Current liabilities
 
$
965,000
 
 
$
1,001,000
 
 
 
 
 
 
 
 
 
Noncurrent liabilities
 
$
5,734,000
 
 
$
4,977,000
 
 
 
 
 
 
 
 
 
Equity
 
$
594,000
 
 
$
1,263,000
 
 
 
 
 
 
 
 
 
Total liabilities and equity
 
$
7,293,000
 
 
$
7,241,000
 
 
BOP and BOPRE [Member]
 
Schedule of Equity Method Investments [Line Items]  
Summarized Financial Information
BOP and BOPRE Condensed Income Statement Information
 
 
Year Ended December 31,
 
2012
 
 
2011
 
 
 
 
 
 
 
Patient revenue
 
$
261,000
 
 
$
-
 
 
 
 
 
 
 
 
 
Net loss
 
$
(578,000
)
 
$
(106,000
)
 
 
 
 
 
 
 
 
USNC's equity in loss
 
$
(65,000
)
 
$
(24,000
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BOP and BOPRE Condensed Balance Sheet Information
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
December 31,
 
 
 
2012
 
 
 
2011
 
 
 
 
 
 
 
 
 
Current assets
 
$
289,000
 
 
$
236,000
 
 
 
 
 
 
 
 
 
Noncurrent assets
 
$
2,897,000
 
 
$
439,000
 
 
 
 
 
 
 
 
 
Total assets
 
$
3,186,000
 
 
$
675,000
 
 
 
 
 
 
 
 
 
Current liabilities
 
$
308,000
 
 
$
-
 
 
 
 
 
 
 
 
 
Noncurrent liabilities
 
$
2,368,000
 
 
$
-
 
 
 
 
 
 
 
 
 
Equity
 
$
510,000
 
 
$
675,000
 
 
 
 
 
 
 
 
 
Total liabilities and equity
 
$
3,186,000
 
 
$
675,000